Withdrawal of prophylaxis against Pneumocystis carinii pneumonia

Lancet

Volumn 353, Issue 9161, 1999, Pages 1287-

  Feinberg, J ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ANTIBIOTIC PROPHYLAXIS; HUMAN; NOTE; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

EID: 0033577483     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00123-3     Document Type: Note

References (9)

1. SM Hammer KE Squires MD Highes A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic milliliter or less N Engl J Med 337 1997 725 733
2. FJJ Palella KM Delaney AC Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 1998 853 860
3. RA Torres M Barr Impact of combination therapy for HIV infection on inparient census N Engl J Med 336 1997 1531 1532
4. B Autran G Carcelain ts Li Positive effects of combined antiretroviral therapy on CD4+T cell homeostasis and function in advanced HIV disease Science 277 1997 112 116
5. NG Pakker DW Notermans RJ de Boer Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation Nat Med 4 1998 208 214
6. MME Schneider JCC Borleffs RP Stolk CAJJ Japers IM Hoepelman Discontinuation of Pneumocystis carinii pneumonia prophylaxis in HIV-1 infected patients treated with highly active antiretroviral therapy Lancet 353 1999 201 203
7. A Rodriguez-Guardado JA Maradona JA Carton L Casado V Asensi Pneumocystis carinii prophylaxis can be discontinued after CD4+cell recovery over 200x105/1 AIDS 12 1998 2355 2356
8. J Phair A Munoz R Detels The risk of Pneumocystis carinii pneumonia among men infected with HIV-1 N Engl J Med 322 1990 161 165
9. Swindells S, Currier JS, Williams P. DACS 071: correlation of viral load and risk for opportunistic infection. 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997, abstr 359.